Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations

Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations

Abstract Background While mainly larger hospitals have introduced routine anti-Xa assays for rivaroxaban (RXA), these are not readily available to smaller hospitals often relying on routine coagulation tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT). The aim of o...

Full description

Bibliographic Details
Main Authors: Alexander Kaserer, Andreas Schedler, Burkhardt Seifert, Donat R. Spahn, Jan-Dirk Studt, Philipp Stein
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Perioperative Medicine
Subjects:
Anticoagulation
Rivaroxaban
Coagulation assays
Surgery
Online Access:http://link.springer.com/article/10.1186/s13741-019-0128-9

Internet

http://link.springer.com/article/10.1186/s13741-019-0128-9

Similar Items